Code pushes pharmas to play nice

 Posted 31 October 2024 AM

There will be less public sniping between rival pharmas under the new Medicines Australia Code of Conduct which has adopted an Intercompany Dialogue Standard, which encourages "more meaningful interaction" between companies and discourages Code complaints as "a competitive tool".

For those thinking of snubbing the new standards, a fine of up to $100,000 awaits companies who don't take the intercompany dialogue seriously. As well, non-member companies will be required to pay a bond of $20,000 when lodging a complaint and where a complaint is upheld, and the subject company is found to be in breach of the Code, the bond will be refunded to the complainant.

To see the whole article, please login